805 results on '"Carroll, Miles"'
Search Results
2. Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea
3. Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon
4. Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study
5. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
6. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
7. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
8. SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
9. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
10. Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
11. Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
12. Mammalian expression systems and vaccination
13. Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
14. Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
15. Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
16. Divergent trajectories of antiviral memory after SARS-CoV-2 infection
17. Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
18. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
19. Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
20. Serological analysis in humans in Malaysian Borneo suggests prior exposure to H5 avian influenza
21. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks
22. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
23. Virus genomes reveal factors that spread and sustained the Ebola epidemic
24. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays
25. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
26. Immunogenicity of COVID‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
27. Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes
28. Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)
29. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
30. Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care
31. Metagenomic identification of a new sarbecovirus from horseshoe bats in Europe
32. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
33. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
34. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
35. Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
36. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
37. Animal models for COVID-19
38. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
39. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
40. Early transmission and case fatality of Ebola virus at the index site of the 2013–16 west African Ebola outbreak: a cross-sectional seroprevalence survey
41. Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents
42. Tozorakimab in patients hospitalised with COVID-19: a phase 2, randomised adaptive platform study (ACCORD-2)
43. Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
44. Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens
45. Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
46. Case study: design and implementation of training for scientists deploying to Ebola diagnostic field laboratories in Sierra Leone: October 2014 to February 2016
47. Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child
48. Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
49. Predicting the past and future evolutionary space of SARS-CoV-2
50. A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.